Deutetrabenazine metabolite M4, the metabolite of Deutetrabenazine (SD-809; GTPL-8707; tetrabenazine-d6; Austedo), which is a vesicular monoamine transporter 2 (VMAT2) inhibitor approved by FDA in 2017 for the treatment of chorea associated with Huntington's disease and tardive dyskinesia.

纯度：≥98%

CAS：1688661-95-1